Trial
NCT02030483
Palbociclib in Combination With Lenalidomide and Dexamethasone for Multiple Myeloma
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Weill Medical College of Cornell University
Collaborators
Celgene Corporation; Pfizer
Condition
Multiple Myeloma
Intervention
Palbociclib
Why stopped
The company providing one of the study drugs withdrew its support due to low enrollment. Therefore, we had to close the study due to lack of funding.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-08-22